Sadaf Fakhra

Sadaf Fakhra

Auto-generated profile, based on publicly available information

Sadaf Fakhra

University of Nevada Las Vegas, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
ASAriyon Schreiber
Ariyon Schreiber
KEKalaimani Elango
Kalaimani Elango
CSChristoph Sossou
Christoph Sossou
SFSadaf Fakhra
Sadaf Fakhra
SAShabada Asad
Shabada Asad
CAChowdhury Ahsan
Chowdhury Ahsan
Background. Currently, the literature regarding the management of COVID-19 induced cardiomyopathy with reduced ejection fraction is limited. In this case report, we present the first documented case of COVID-19 induced myocardial stunning leading to severely reduced LV systolic function that was reversed by the administration of corticosteroids and tocilizumab. Case Summary. A 39-year-old female with well controlled systemic hypertension, tested positive for SARS-CoV-2 RNA and underwent self-isolation for 14 days. Patient presented to our facility a month later with one-week history of progressively worsening generalized body aches, chills, fever, watery diarrhea, nausea with associated mild dry nonproductive cough, shortness of breath and nonspecific chest pain. Initial labs demonstrated that she was COVID-19 positive, elevated troponin (4.295ng/ml), and elevated BNP (2,291pg/ml). Her initial Transthoracic echocardiography demonstrated an Left ventricular ejection fraction (LVEF) of 20-25 with apical akinesis. After administration of tocilizumab and corticosteroids, patient demonstrated interval improvement with LVEF improving to 50-55 within days. Her labs confirmed these findings with improved troponin (0.858ng/ml) and BNP (209pg/ml). Discussion. This case demonstrates that it can be safe and efficacious to use tocilizumab and corticosteroids in patients with COVID-19 induced cardiomyopathy. These finding suggest that cytokine storm is the predominant mechanism by which COVID-19 induced cardiomyopathy occurs. Additional studies are required to determine the role of corticosteroids and tocilizumab in management of this condition.

26 May 2023 in Interventional Cardiology: Reviews, Research, Resources
Verified
Journal Article
Open access
PDF file
YSyasar sattar
yasar sattar
PSPrasanna M Sengodan
Prasanna M Sengodan
MCMustafa Sajjad Cheema
Mustafa Sajjad Cheema
NJNismat Javed
Nismat Javed
SAShoaib Ashraf
Shoaib Ashraf
RDRamesh Daggubati
Ramesh Daggubati
Background: Radiation exposure is an occupational hazard for interventional cardiologists and cardiac catheterisation laboratory staff that can manifest with serious long-term health consequences. Personal protective equipment, including lead jackets and glasses, is common, but the use of radiation protective lead caps is inconsistent. Methods: A systematic review qualitative assessment of five observational studies using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines protocol was performed. Results: It was concluded that lead caps significantly reduce radiation exposure to the head, even when a ceiling-mounted lead shield was present. Conclusion: Although newer protective systems are being studied and introduced, tools, such as lead caps, need to be strongly considered and employed in the catheterisation laboratory as mainstay personal protective equipment.

23 September 2022 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
SFSadaf Fakhra
Sadaf Fakhra
AJAwad Javaid
Awad Javaid
ASAmaan Shafi
Amaan Shafi
CAChowdhury Ahsan
Chowdhury Ahsan
Patients with a bicuspid aortic valve have increased risk of infective endocarditis, but common organisms are not always the culprit. We describe a case of an otherwise healthy young gentleman with bicuspid aortic valve who experienced Abiotrophia defectiva endocarditis. The aim of this case report is to highlight an uncommon cause of endocarditis associated with significant morbidity and mortality in order to improve the care provided by trainees and clinicians. A 37-year-old male presented with a 1-month history of fever, weight loss, myalgia, and night sweats. On transoesophageal echocardiography, he was found to have a bicuspid aortic valve with large vegetation and severe aortic insufficiency. Blood cultures were positive for A. defectiva. The endocarditis was successfully treated with surgical aortic valve replacement and 6 weeks of antibiotic therapy. Bicuspid valves are known to have increased susceptibility to endocarditis. The difficulty of isolating A. defectiva typically leads to delayed diagnosis and significant complications. This case is a reminder to have a high degree of suspicion for organisms which are rare and difficult to isolate because prompt recognition and surgical intervention may improve the outcome of care.

18 July 2024 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SSSafia Shaikh
Safia Shaikh
MHMohammad Hamza
Mohammad Hamza
PUPrakash Upreti
Prakash Upreti
MAMohammad Akkawi
Mohammad Akkawi
KRKripa Rajak
Kripa Rajak
MAM. Chadi Alraies
M. Chadi Alraies

1 December 2022 in Current Problems in Cardiology
Verified
Journal Article
Closed access
CSChristoph W. Sossou
Christoph W. Sossou
SFSadaf Fakhra
Sadaf Fakhra
KBKavita Batra
Kavita Batra
BNBrice Nouthe
Brice Nouthe
AOAlexis Okoh
Alexis Okoh
CAChowdhury H. Ahsan
Chowdhury H. Ahsan

18 December 2023 in Expert Review of Cardiovascular Therapy
Verified
Journal Article
Closed access
SFSadaf Fakhra
Sadaf Fakhra
MFMohammed Faisaluddin
Mohammed Faisaluddin
YSYasar Sattar
Yasar Sattar
DDDanielle DeCicco
Danielle DeCicco
AAAsmaa Ahmed
Asmaa Ahmed
SBSudarshan Balla
Sudarshan Balla
Takotsubo syndrome (TTS), also known as stress-induced cardiomyopathy, can be complicated by shock. The outcomes of patients with TTS complicated with cardiogenic shock (CS) versus mixed cardiogenic and septic shock (MS) is not known. We queried Nationwide Inpatient Sample (NIS) from 2009-2020 to compare TTS patients with CS and MS using International Classification of Disease, Ninth & Tenth Edition, Clinical Modification (ICD- 9 & 10-CM) coding. In-hospital outcomes were compared using one: one propensity score matched (PSM) analysis. The primary outcome was in-hospital mortality. Of 23,126 patients with TTS 17,132 (74%) had CS, and 6,269 (26%) had MS. The mean age was 67 years in CS and 66 years in MS, and majority of patients were female (n = 17,775, 77%). On adjusted multivariate analysis, MS patients had higher odds of in-hospital mortality (aOR 1.44, 95% CI 1.36-1.52), AKI (aOR 1.53, 95% CI 1.48-1.58), pressor requirement (aOR 1.37, 95% CI 1.25-1.50). However, had lower odds of MCS use (aOR 0.44, 95% CI 0.40-0.48) and cardiac arrest (aOR: 0.81, 95% CI 0.73-0.90) (p-value <0.0001). Mean LOS and inflation-adjusted hospital charges were higher in MS. MS in the setting of TTS have higher rates of in-hospital mortality, AKI, and pressor requirements.